Spinnaker Opportunities will buy the entire issued share capital of the Israeli medical cannabis R&D firm, according to the deal.

The Israeli medical cannabis R&D company's extraction and vaporization solutions will also be marketed in the US through Constance Therapeutics, a US-based medical cannabis extraction company.

November 1, 2017 | The Israeli medical cannabis R&D company Kanabo Research snagged a top award at the recent CannaTech UK event which took place in London on October 26. Kanabo took home the coveted “Live Investor Pitch Award” for its VapePod, a medical device that works with the company’s patent-pending formulations of “targeted, clinically […]